文献
J-GLOBAL ID:201702251744722810
整理番号:17A0972148
トリプルネガティブ乳癌はにおけるタキサン抵抗性CD49f+腫瘍始原集団の動力学【Powered by NICT】
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
著者 (27件):
Gomez-Miragaya Jorge
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Palafox Marta
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Pare Laia
(Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain)
,
Yoldi Guillermo
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Ferrer Irene
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Vila Sergi
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Galvan Patricia
(Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain)
,
Galvan Patricia
(Translational Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain)
,
Pellegrini Pasquale
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Perez-Montoyo Hector
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Igea Ana
(Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain)
,
Munoz Purificacion
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Esteller Manel
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
,
Esteller Manel
(Unitat de Bioquimica i Biologia Molecular, Departament de Ciencies Fisiologiques II, Universitat de Barcelona-IDIBELL, 08908 Barcelona, Spain)
,
Esteller Manel
(Institucio Catalana de Recerca i Estudis Avancats (ICREA), Pg. Lluis Companys 23, 08010 Barcelona, Spain)
,
Nebreda Angel R.
(Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain)
,
Nebreda Angel R.
(Institucio Catalana de Recerca i Estudis Avancats (ICREA), Pg. Lluis Companys 23, 08010 Barcelona, Spain)
,
Urruticoechea Ander
(Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain)
,
Morilla Idoia
(Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain)
,
Pernas Sonia
(Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain)
,
Climent Fina
(Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain)
,
Soler-Monso Maria Teresa
(Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain)
,
Petit Ana
(Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain)
,
Serra Violeta
(Experimental Therapeutics Group, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain)
,
Prat Aleix
(Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain)
,
Prat Aleix
(Translational Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain)
,
Gonzalez-Suarez Eva
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L’Hospitalet de Llobregat, 08908 Barcelona, Spain)
資料名:
Stem Cell Reports
(Stem Cell Reports)
巻:
8
号:
5
ページ:
1392-1407
発行年:
2017年
JST資料番号:
W3132A
ISSN:
2213-6711
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)